期刊文献+

TrkAsiRNA表达载体构建及对TrkA基因表达的抑制

Construction of siRNA expression vector of trkA and its inhibition on the expression of trkA
下载PDF
导出
摘要 目的 构建具有特异阻断TrkA基因功能的siRNA表达系统 ,为前列腺癌基因治疗提供新的方法。方法 根据Genbank提供的TrkA基因mRNA序列 ,应用设计软件设计特异性的短链寡核苷酸 ,化学合成后经退火形成双链DNA片段 ,克隆到pSlincerTM2 1 U6载体中 ,用BamHⅠ和HindⅢ双酶切和序列测定对重组体进行鉴定 ,最后将构建的表达载体转染前列腺癌细胞株 ,观察对TrkA基因表达的影响。结果 酶切和序列测定表明 ,成功构建了siRNA表达载体 ,能够抑制细胞内TrkA基因表达。结论 本研究构建的siRNA表达载体 ,具有阻断TrkA基因的表达的功能 ,为前列腺癌基因治疗提供新的有效的方法。 Objective To construct the specific siRNA expression vector that can block TrkA gene function, which provides a new approach to the prevention of prostate cancer. Methods Specific short chain oligonucletide was designed by using the siRNA software according to the mRNA sequence provided by genebank, the double chain DNA sequenct was gained through annealing after chemosynthesis and was inserted to psilencer siRNA expression vector, the recombinant expression vector was evaluated by using enzyme cutting and sequencing. At last, the constructed TrkA gene expression was observed. Results Identifcation by enzyme cutting and sequencing showed that the expression vector was constructed successfully, and could inibit the gene expression effiectively. Conclusion The constructed siRNA expression vector can block the TrkA gene expression, it will enable us to develop an approach to cure prostate cancer.
出处 《解剖学研究》 CAS 2004年第3期174-176,共3页 Anatomy Research
  • 相关文献

参考文献7

  • 1Djakiew DA,Pflug BR,Delsite R,et al.Chemotaxis and chemokinesis of hanan prostate tumor cell lines in response to htman prostate stromal cell secretory proteins containing nerve growth factor-like protein,Cancer Res,1993,53:1416~ 1420.
  • 2Pflug,BR,Onoda M,Lynch J,et lal.Reduced expression of the low affinity never growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines.Cancer Res,1992,52: 5403~5406.
  • 3Brummelkamp TR,Bernards R,Agami R.et al.Asystem for stable expression of short interfering RNAs in mammalian cells.Science,2002:19;550~553.
  • 4Weeraratna AT,Arnold JT,George DJ,et al.Rational basis for trk inhition therapy for prostate cancer.Prostate,2000,45:140 ~148.
  • 5George DJ,Dionne CA,Jani J,et al.Sustained in vivo regression of Duning Hrat prostate cancers treated with combinations of androgen ablation and trk tyrosinre kinase inhibitors CEP-751 (KT-6587) orcep-701 ( KT-5555 ) .Cancer Res,1999,59:2395~2401.
  • 6Lee NS,Dohjima T,Bauer G,et al.Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.Nat Biotechnol,2002,20:500~ 505.
  • 7Miyagishi M,Taira K.U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells.Nat Biotechnol,2002,20:497~500.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部